Medical cannabis: Exploring therapeutic perspectives and regulatory context

The utilization of medical cannabis, specifically the therapeutic potential of cannabinoids, has garnered significant attention in recent years. This literature review aims to delve into the intersection between therapeutic perspectives and the regulatory context surrounding medical cannabis. Key terms such as medical cannabis, cannabinoids, regulation, chronic pain, and multiple sclerosis (MS) will be explored to provide a comprehensive understanding of the subject.

Therapeutic applications of medical cannabis will be examined, with particular focus on its potential in managing chronic pain and alleviating symptoms associated with multiple sclerosis. Furthermore, the complex regulatory landscape surrounding medical cannabis will be analyzed, taking into account various legal frameworks, guidelines, and constraints imposed by governing bodies.This article highlights emerging scientific evidence supporting the use of medical cannabis, including the efficacy of cannabinoids in pain management and their impact on multiple sclerosis symptoms. Additionally, it will address the challenges faced by healthcare professionals, patients, and policymakers due to varying regulations across jurisdictions.